According to the median value of NFAT2 nuclear expression as a classified condition, it was found that the survival condition of the low-expression group of NFAT2 was better than that of the high-expression group, which indicated that the nuclear levels of NFAT2 could affect the survival of BLCA patients (Figure 12A). Here, NFATC1 is linked to bladder transitional cell carcinoma.